That's important, since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (brownstone research). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. This was a breakthrough almost no one noticed. But it's going to have profound ramifications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown investor prediction). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly substantially before going higher - self-driving cars. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. But that's not the huge concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. united states. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous excellent personal companies on the verge of striking the general public markets And I have actually been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our normal beat (jeff brown investor prediction). And when it concerns tech investing, we leave it to the specialists. The good news is, we have a number of such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (genetic sequencing companies jeff brown). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing rapid growth and creating extraordinary chances for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown biotech stock pick for 2020. However despite what lots of readers might believe, this is a pattern that's just beginning. Even though the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (korean actress). Losing two months of production and sales truly impacts how lots of 5G gadgets are offered in the calendar year. When you consider all of that, offering 250 million systems is remarkable. More importantly, the hold-ups caused by the pandemic produced a heap of pent-up need. Which demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - toxic tech 5 tech darlings. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 different stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services start to be offered (jeff brown market predictions). That's when we start to see applications operating on 5G networks. Consider things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: Many people do not truly appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances moving forward will be enormous. Stepping away from 5G, the next important innovation I anticipate in 2021 is CRISPR hereditary editing. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was mostly a niche innovation that wasn't well understood. And throughout that time, there were actually just three companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating illness and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing amazing returns. This entire market is efficiently a greenfield opportunity.
There's room for many business to exist in this area. exponential growth. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is essential since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug therapies produced using this technology. This was among those advancements that almost nobody saw. However it's going to have extensive implications for curing disease. And, naturally, there will be lots of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back possibly significantly before going higher. I have actually been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - last week. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. tech stocks. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, but we could not independently confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like ability to pick winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an outstanding viewpoint on the marketplace. He's always on the hunt for new chances, and he shares much of his finest picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted a few of the biggest financial events of the previous 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best whenever, but Jeff Brown's precise forecasts have actually earned him legions of devoted fans. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research study uses several research services with a large range of specializations - korean actress.
The business is also connected with Bonner & Partners, another well-respected research publisher - jeff brown 1 biotech company. On its website, Brownstone states its objective is to offer retail financiers with professional-grade research: "For too long, the very best financial investment research study has actually not been available to individual financiers. It has actually been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown prediction for 2021. The mission of Brownstone Research is to make that kind of proprietary research study offered to any investors looking to get an edge in the marketplaces. The objective is easy to provide special and profitable financial investment research found no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. genetic sequencer stock jeff brown. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown thinks S.A.V. brownstone research stock. could be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge technologies: artificial intelligence and electric cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the vehicle industry's Holy Grail. As you know, electrical lorries and self-driving car stocks have actually been substantial this year, however the Wall Street machine has been huge on hype without much concrete outcome. Despite a drastic boost in competition over the previous few years, Brown still believes Musk has the finest possibility of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Basically, this innovation would allow you to lease out your vehicle as a self-governing, self-driving taxi when you're not using it. You merely get out of the vehicle and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the revenues. It sounds outrageous, but it might be closed than you believe.